Damaj Bassam 4/A
4/A · INNOVUS PHARMACEUTICALS, INC. · Filed Feb 13, 2013
Insider Transaction Report
Form 4/AAmended
Damaj Bassam
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2013-02-02$0.48/sh+250,406$118,993→ 3,459,877 total
Holdings
- 6,108(indirect: By IRA)
Common Stock
- 1,297,836(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]On February 5, 2013, the Reporting Person filed a Form 4 reporting an incorrect amount of securities beneficially owned following the reported transaction.